Role of Duloxetine as Adjuvant in Chemotherapy Induced Peripheral Neuropathic Pain-An Update
Open Access
- 29 June 2016
- journal article
- Published by Peertechz Publications Private Limited in Journal of Addiction Medicine and Therapeutic Science
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot studySupportive Care in Cancer, 2011
- Block of Neuronal Na+Channels by Antidepressant Duloxetine in a State-dependent MannerAnesthesiology, 2010
- A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CASupportive Care in Cancer, 2010
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02Supportive Care in Cancer, 2009
- Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathyCancer, 2008
- Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic SymptomsJournal of Pain and Symptom Management, 2008
- Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathyCancer, 2007
- The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy‐induced peripheral neurotoxicity: comparison with the National Cancer Institute‐Common Toxicity ScaleJournal of the Peripheral Nervous System, 2007
- A Double-Blind, Randomized Multicenter Trial Comparing Duloxetine with Placebo in the Management of Diabetic Peripheral Neuropathic PainPain Medicine, 2005
- Duloxetine vs. placebo in patients with painful diabetic neuropathyPain, 2005